In a recent study, it was found that CD47 deficiency or pyroglutamylation inhibition increases myeloid cell-mediated T-ALL killing; QPCTL deficiency reduced 78% of the binding between CD47 and SIRPα (36). Here, CD47 is linked to acute lymphoblastic leukemia.